Displaying 69 Switzerland Pharma companies
Sorting: Score
Filter Sorting & Filter 3
Export
Switzerland Pharma All business models
company score funding investors employees industries biz model city contact
SkyCell

Temperature controlled containers for the pharmaceutical industry.
46
$57M · Series C M&G Investments, MVM Life Science Partners 101 to 250 Pharma, Manufacturing B2B Zürich, Switzerland •••••••••••@skycell.ch
Anjarium Biosciences

Gene therapy research to tackle genetic diseases.
37
$59M · Series A Gimv 1 to 10 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@anjarium.com
Noema Pharma

Clinical-stage central nervous system (CNS) technology.
37
$110M · Series B Sofinnova Partners, Forbion Capital Partners, BioMedPartners 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@noemapharma.com
GlycoEra

Glycanengineering platform.
31
$49M · Series A Sofinnova Partners 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@glycoera.com
BioVersys

Novel antiobiotic researcher to fight antimicrobial resistance.
26
$8M · Series C AMR Action Fund 1 to 10 Biotech, Pharma B2B Basel, Switzerland •••••••••••@bioversys.com
Nanolive

Nanolive has developed a disruptive proprietary technology.
26
$20M Swisscom Ventures 1 to 10 Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence B2B, SaaS Lausanne, Switzerland •••••••••••@nanolive.ch
Mysthera Therapeutics

Developer of oral therapeutics to treat complex autoimmune diseases.
26
$3M · Seed Forty51 Ventures 1 to 10 Health Tech, Pharma Basel, Switzerland •••••••••••@mystheratx.com
Pharvaris

Pharvaris is a clinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients.
23
$80M · Series C 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Zug, Switzerland •••••••••••@pharvaris.com
T3 Pharmaceuticals

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
20
$26M · Series C 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Basel, Switzerland •••••••••••@t3pharma.com
BC Platforms

BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine.
20
$20M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Zürich, Switzerland •••••••••••@bcplatforms.com
Cimeio Therapeutics

Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
20
$50M · Series A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Basel, Switzerland •••••••••••@cimeio.com
Rejuveron Life Sciences

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.
20
$25M · Series A 1 to 10 Health Tech, Fintech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@rejuveron.com
ImmunOs Therapeutics

Immunotherapy platform for cancer.
17
$330k · Pre Seed Lightspeed Venture Partners, BioMedPartners, Gimv 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@immunostherapeutics.com
Navignostics

Navignostics aims to identify the ideal treatment to each cancer patient’s disease.
17
$7M 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma Zürich, Switzerland •••••••••••@navignostics.com
NextImmune

NextImmune is a privately held biotechnology company.
17
$154k · Pre Seed Venture Kick Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@nextimmune.com
Flowbone

We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening
17
$166k · Pre Seed Venture Kick 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech B2B Lausanne, Switzerland •••••••••••@flowbone.com
Chord Therapeutics

Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.
17
$16M · Series A 11 to 50 Health Tech, Biotech, Pharma B2B Geneva, Switzerland •••••••••••@chordtherapeutics.com
Testmate Health

Testmate Health builds self-testing kits that allow you you skip the waiting room & get results at home in minutes.
17
$1M · Seed Next Ventures 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B, B2C Lausanne, Switzerland •••••••••••@testmatehealth.com
Versameb

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
17
$6M · Seed 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@versameb.com
Bloom Biorenewables Ltd

Bloom Biorenewables is making biomass a true alternative to petroleum.
14
$3M 1 to 10 Climate Tech & Green Tech, Biotech, Pharma, Energy & Nuclear, Manufacturing B2B Fribourg, Switzerland •••••••••••@bloombiorenewables.com
Molecule

Molecule is a software platform used to accelerate innovation in the pharmaceutical industry.
12
N/A BACKED VC, Speedinvest, BoxGroup 11 to 50 Health Tech, Fintech, Crypto & web3, Biotech, Deep Tech, Pharma B2B, Marketplace Schaffhausen, Switzerland •••••••••••@molecule.to
Galventa

Galventa Provides Pharmaceutical Manufacturing Services.
10
$807k · Seed 1 to 10 Health Tech, Biotech, Pharma, Fitness, Manufacturing, Service Industry B2B Saint Gallen, Switzerland •••••••••••@galventa.com
Cellestia

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
7
N/A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Basel, Switzerland •••••••••••@cellestia.com
Actando

Learning platform for the pharma industry.
4
N/A 11 to 50 Edtech, Pharma B2B, SaaS Geneva, Switzerland •••••••••••@actando.com
Mysthera Therapeutics

Developer of oral therapeutics to treat complex autoimmune diseases.
4
N/A 1 to 10 Health Tech, Pharma Basel, Switzerland •••••••••••@